BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1.06 Cr | ₹-0.85 Cr | ₹10 Cr | ₹-4.81 Cr | ₹12 Cr |
What is the latest Cash Flow from Financing Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹1.06 Cr |
| Mar2024 | ₹-0.85 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹-4.81 Cr |
| Mar2021 | ₹12 Cr |
How is Cash Flow from Financing Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.06 Cr | Positive | |
| Mar2024 | ₹-0.85 Cr | Negative | |
| Mar2023 | ₹10 Cr | Positive | |
| Mar2022 | ₹-4.81 Cr | Negative | |
| Mar2021 | ₹12 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹288.8 Cr | -0% | -19.4% | 45.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -0% |
-19.4% |
45.2% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses